Business News

Delaying the second dose of the COVID vaccine may cut back the variety of deaths: Research

In order to achieve this, a number of conditions must be met.

Grow your business,
Not your inbox

Stay up to date and subscribe to our daily newsletter now!

Can
13, 2021

2 min read

This article was translated using AI technologies from our Spanish edition. Errors can occur as a result of this process.

Research published in the British Medical Journal stated that delaying the second dose of the COVID-19 vaccine could reduce the number of deaths in people under 65 by 20 percent.

To achieve this, however, some conditions must be met, e.g. E.g. A vaccine with a minimum effectiveness of 80% and a vaccination rate of 0.1% to 0.3% of the population per day.

The publication states: “The delayed second dose strategy for those under 65 years of age has been consistently followed with all vaccination rates tested. A delayed second dose strategy, at least for those under 65 years of age, could lead to a reduction in the cumulative dose Mortality under certain conditions ”.

According to scientists, this method could prevent between 46 and 26 deaths per 100,000 people. The assumption is that the necessary protection can be achieved after the first dose of highly potent vaccines, but this remains a debate.

They add that the risk of developing new vaccine-resistant variants of the disease is proportional to the time it takes to vaccinate the world's population.

Related Articles